We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TAK icon
1
Takeda Pharmaceutical
TAK
$69.2B
$69.2B $21.65 1.03%
TEVA icon
2
Teva Pharmaceutical Industries
TEVA
$50.5B
$50.5B $43.30 2.7%
HLN icon
3
Haleon
HLN
$40.5B
$40.5B $9.23 0.65%
ZTS icon
4
Zoetis
ZTS
$34B
$34B $83.69 0.16%
UTHR icon
5
United Therapeutics
UTHR
$25B
$25B $586.16 0.85%
VTRS icon
6
Viatris
VTRS
$23.8B
$23.8B $20.73 0.43%
NBIX icon
7
Neurocrine Biosciences
NBIX
$16.8B
$16.8B $166.33 0.64%
ELAN icon
8
Elanco Animal Health
ELAN
$13.2B
$13.2B $26.45 1.23%
RDY icon
9
Dr. Reddy's Laboratories
RDY
$12.3B
$12.3B $14.71 0.2%
ALKS icon
10
Alkermes
ALKS
$7.89B
$7.89B $46.97 0.13%
KNSA icon
11
Kiniksa Pharmaceuticals
KNSA
$7.46B
$7.46B $94.94 1.44%
AMRX icon
12
Amneal Pharmaceuticals
AMRX
$7.37B
$7.37B $21.16 1.03%
LNTH icon
13
Lantheus
LNTH
$6.66B
$6.66B $101.78 0.19%
SUPN icon
14
Supernus
SUPN
$6.01B
$6.01B $28.93 2.66%
LQDA icon
15
Liquidia
LQDA
$5.11B
$5.11B $56.68 1.27%
HIMS icon
16
Hims & Hers Health
HIMS
$4.4B
$4.4B $18.78 4.82%
AMLX icon
17
Amylyx Pharmaceuticals
AMLX
$3.67B
$3.67B $28.54 5.78%
BHC icon
18
Bausch Health
BHC
$3.17B
$3.17B $8.48 1.56%
XERS icon
19
Xeris Biopharma Holdings
XERS
$3.05B
$3.05B $16.68 0.12%
HCM icon
20
HUTCHMED
HCM
$2.57B
$2.57B $14.80 0.67%
RGC icon
21
Regencell Bioscience
RGC
$2.31B
$2.31B $4.66 5.67%
PBH icon
22
Prestige Consumer Healthcare
PBH
$2.27B
$2.27B $47.95 3.81%
PRGO icon
23
Perrigo
PRGO
$2.27B
$2.27B $16.32 0.49%
BCRX icon
24
BioCryst Pharmaceuticals
BCRX
$1.94B
$1.94B $7.53 1.05%
ETON icon
25
Eton Pharmaceutcials
ETON
$1.86B
$1.86B $64.40 0.74%

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 79 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $372B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $69.2B, Teva Pharmaceutical Industries (TEVA) at $50.5B and Haleon (HLN) at $40.5B.

Among institutional investors, Trulieve Cannabis (TRLV) drew the most net new fund positions in Q2 2026: 123 funds opened new positions, taking total fund holders up 121 (2,017%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.